Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at ...

Argobio successfully facilitated fundraising and syndication process, following its earlier role in creating and pre-seed funding EnodiaFinancing ...

Understand the role of reproductive biotech in overcoming biological limits in fertility treatments and enhancing success ...

Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at the point of synthesis, today announced it has raised ?20.7 million (US$25 ...

Somite, an AI-native TechBio company building the first universal virtual cell-signaling model, today announced its new identity, Cellular Intelligence. This rebrand reflects the company's vision to ...

ASPIRO is the first multi-patient, multi-center clinical trial of an autologous cell therapy for Parkinson's disease. It is evaluating safety, tolerability, and preliminary efficacy of ANPD001 in ...

“We are pleased to welcome Behzad and Karen to 3T Biosciences at a pivotal stage for the company,” said Stefan Scherer, M.D., ...

Building on their existing collaboration, the companies have signed a new agreement to focus on lead optimization of drug candidates identified by Variational AI’s Enki™ generative AI platform and ...

Collaboration leverages Cartography’s cutting-edge ATLAS and SUMMIT platforms to identify tumor-selective antigens; Pfizer to lead therapeutic development –– Cartography to receive upfront, near-term ...

Researchers at Duke University combined Dynamic Optical Contrast Imaging (DOCI) with AI to improve thyroid cancer detection ...

Boston Dynamics product lead Aya Durbin discusses Atlas, industrial humanoid robots, and what it takes to make humanoids ...

After a sluggish first half, the drug and biotech sector has staged a recovery over the past two to three months. This ...